Latest News

Drug shows potential to delay onset or progression of Alzheimer's disease

An anti-atherosclerosis drug greatly reduced blood-brain barrier (BBB) leaks in animal models with diabetes and hypercholesterolemia and linked BBB permeability with amyloid peptide deposits at the site of early Alzheimer's pathology.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Using Twitter to probe political polarization

  • Wobbly no more: Work on analogical processing helps children learn key engineering principle

  • How are ordinary consumers transforming the fashion business?

  • When are consumers more likely to rely on feelings to make decisions?

  • Saving money: Do consumers spend less if they think about the future?

  • Cultivating timeflow: Can consumers shape how they experience time?

  • Scientists one step closer to finding how to repair damaged nerve cells

  • Chronic loneliness in older adults leads to more doctors' office visits, study finds

  • Do consumers think products are better when companies donate to charity?

  • A matter of taste: When do products benefit from mixed reviews?

  •